Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec 19:9:1096867.
doi: 10.3389/fmed.2022.1096867. eCollection 2022.

Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Michael Kasperkiewicz  1 , Stefan Tukaj  2
Affiliations
Comment

Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study

Michael Kasperkiewicz et al. Front Med (Lausanne). .
No abstract available

Keywords: COVID-19; SARS-CoV-2; autoimmune bullous diseases; bullous pemphigoid; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment in

Comment on

  • Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.
    Maronese CA, Caproni M, Moltrasio C, Genovese G, Vezzoli P, Sena P, Previtali G, Cozzani E, Gasparini G, Parodi A, Atzori L, Antiga E, Maglie R, Moro F, Mariotti EB, Corrà A, Pallotta S, Didona B, Marzano AV, Di Zenzo G. Maronese CA, et al. Front Med (Lausanne). 2022 Feb 28;9:841506. doi: 10.3389/fmed.2022.841506. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35295599 Free PMC article.

References

    1. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. (2013) 381:320–32. 10.1016/S0140-6736(12)61140-4 - DOI - PubMed
    1. Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. (2019) 394:882–94. 10.1016/S0140-6736(19)31778-7 - DOI - PubMed
    1. Kasperkiewicz M, Yale M, Strong R, Zillikens D, Woodley DT, Recke A. COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. (2021) 35:e418–21. 10.1111/jdv.17228 - DOI - PMC - PubMed
    1. Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, et al. . Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. (2020) 34:e302–3. 10.1111/jdv.16525 - DOI - PMC - PubMed
    1. Kasperkiewicz M, Schmidt E, Amagai M, Fairley JA, Joly P, Murrell DF, et al. . Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. (2021) 35:e412–4. 10.1111/jdv.17207 - DOI - PMC - PubMed